Dr. Nibley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5131 Cottonwood St
L2
Murray, UT 84107Phone+1 801-263-3416Fax+1 801-263-3428
Education & Training
University of Utah HealthFellowship, Hematology and Medical Oncology, 1994 - 1998- University of Utah HealthResidency, Internal Medicine, 1991 - 1994
George Washington University School of Medicine and Health SciencesClass of 1991
Certifications & Licensure
UT State Medical License 1992 - 2026
ID State Medical License 2022 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy Start of enrollment: 2019 Dec 15
Publications & Presentations
PubMed
- 5 citationsHydration requirements in patients receiving highly emetogenic chemotherapy.Randy Erickson, Neil Nebughr, Michael Mosier, William Nibley
Future Oncology. 2019-03-01 - An inv(16) in Ph-negative cells of a chronic myelogenous leukemia patient after imatinib treatment.Leslie R. Rowe, Arthur R. Brothman, William E. Nibley, Michael R. Gaffney, Zhong Chen
Cancer Genetics and Cytogenetics. 2007-04-01 - 7 citationsPatterns of organ-specific engraftment by stem cell subsets and committed progenitors.William E. Nibley, Suzanne J. Pohlmann, Gerald J. Spangrude
Stem Cells. 1997-04-01
Press Mentions
Consolidation Leaves Just Two Major Oncology Players in Salt Lake MarketJanuary 20th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
